Intravenous Infusions (XGHA:IIL) Net Margin % : 0.00% (As of . 20)

View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Intravenous Infusions's Net Income for the six months ended in . 20 was GHS0.00 Mil. Intravenous Infusions's Revenue for the six months ended in . 20 was GHS0.00 Mil. Therefore, Intravenous Infusions's net margin for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for Intravenous Infusions's Net Margin % or its related term are showing as below:

XGHA:IIL's Net Margin % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 3.065
* Ranked among companies with meaningful Net Margin % only.

Intravenous Infusions Net Margin % Historical Data

The historical data trend for Intravenous Infusions's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions Net Margin % Chart

Intravenous Infusions Annual Data

Trend

Net Margin %

Intravenous Infusions Semi-Annual Data

Net Margin %

Competitive Comparison of Intravenous Infusions's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Intravenous Infusions's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intravenous Infusions's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intravenous Infusions's Net Margin % distribution charts can be found below:

* The bar in red indicates where Intravenous Infusions's Net Margin % falls into.

Intravenous Infusions Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Intravenous Infusions's Net Margin for the fiscal year that ended in . 20 is calculated as

Net Margin	=	Net Income (A: . 20 )	/	Revenue (A: . 20 )
	=		/
	=	%

Intravenous Infusions's Net Margin for the quarter that ended in . 20 is calculated as

Net Margin	=	Net Income (Q: . 20 )	/	Revenue (Q: . 20 )
	=		/
	=	%

Intravenous Infusions (XGHA:IIL) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Intravenous Infusions Net Margin % Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Intravenous Infusions (XGHA:IIL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA

Website

https://www.iil.com.gh

Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.